The 2024 biopharma M&A landscape: An overview

from pharmaphorum Podcast · host pharmaphorum

It's been a couple of months since pharma’s annual JP Morgan Chase Healthcare Conference, where the mood around pharma M&A this year was optimistic, albeit with a few caveats. On today’s podcast, host Jonah Comstock is joined by Cody Powers, principal of portfolio and business development at ZS Associates, to discuss those trends and predictions and how they’re shaking out so far.

Episode metadata supplied by the publisher feed · Published Feb 29, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

The 2024 biopharma M&A landscape: An overview

0:00 31:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of pharmaphorum Podcast?

This episode is 31 minutes long.

When was this pharmaphorum Podcast episode published?

This episode was published on February 29, 2024.

Can I download this pharmaphorum Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!